Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Fulgent Genetics Inc (FLGT)

Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 546,590
  • Shares Outstanding, K 30,587
  • Annual Sales, $ 289,210 K
  • Annual Income, $ -167,830 K
  • EBIT $ -81 M
  • EBITDA $ 62 M
  • 60-Month Beta 1.51
  • Price/Sales 1.79
  • Price/Cash Flow 5.22
  • Price/Book 0.45

Options Overview Details

View History
  • Implied Volatility 47.29% ( -9.12%)
  • Historical Volatility 54.66%
  • IV Percentile 60%
  • IV Rank 46.54%
  • IV High 82.54% on 10/18/24
  • IV Low 16.61% on 06/17/24
  • Put/Call Vol Ratio 0.17
  • Today's Volume 35
  • Volume Avg (30-Day) 75
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 1,558
  • Open Int (30-Day) 1,299

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.40
  • Number of Estimates 2
  • High Estimate -0.35
  • Low Estimate -0.45
  • Prior Year -0.02
  • Growth Rate Est. (year over year) -1,900.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.56 +7.91%
on 11/19/24
22.87 -21.86%
on 11/06/24
-1.73 (-8.83%)
since 10/22/24
3-Month
16.56 +7.91%
on 11/19/24
23.99 -25.50%
on 08/26/24
-5.18 (-22.47%)
since 08/22/24
52-Week
16.56 +7.91%
on 11/19/24
30.68 -41.75%
on 12/22/23
-9.61 (-34.97%)
since 11/22/23

Most Recent Stories

More News
Got $2,500? This Dirt Cheap Growth Stock Could Be Worth Buying Hand Over Fist

Fulgent is moving past its pandemic-era business, and that's a good thing.

NVDA : 141.95 (-3.22%)
FLGT : 17.87 (+5.43%)
Better Diversified Biotech Stock: 23andMe vs. Fulgent Genetics

Neither has a traditional business model, but that could be an asset for both.

ME : 3.11 (-3.72%)
FLGT : 17.87 (+5.43%)
2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years

Both are experiencing a bit of a hangover from declining COVID-19-related sales.

BNTX : 113.13 (+4.53%)
PFE : 25.65 (+2.07%)
FLGT : 17.87 (+5.43%)
Fulgent Reports First Quarter 2023 Financial Results

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today...

FLGT : 17.87 (+5.43%)
Fulgent Genetics to Announce First Quarter 2023 Financial Results on Friday May 5, 2023

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today...

FLGT : 17.87 (+5.43%)
Fulgent Reports Fourth Quarter and Full Year 2022 Financial Results

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent”, or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today...

FLGT : 17.87 (+5.43%)
Fulgent Genetics Launches New Beacon787 Expanded Carrier Screening Panel

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today...

FLGT : 17.87 (+5.43%)
Fulgent to Participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference

Fulgent, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced...

FLGT : 17.87 (+5.43%)
Fulgent Genetics to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 28, 2023

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based genetic testing and therapeutics company focused on transforming patient care in oncology, infectious and...

FLGT : 17.87 (+5.43%)
INVESTIGATION ALERT REMINDER: Scott+Scott Attorneys at Law LLP Investigates Fulgent Genetics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – FLGT

Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, reminds investors of its continued investigation of certain directors and officers...

FLGT : 17.87 (+5.43%)

Business Summary

Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process...

See More

Key Turning Points

3rd Resistance Point 19.08
2nd Resistance Point 18.52
1st Resistance Point 18.19
Last Price 17.87
1st Support Level 17.30
2nd Support Level 16.74
3rd Support Level 16.41

See More

52-Week High 30.68
Fibonacci 61.8% 25.29
Fibonacci 50% 23.62
Fibonacci 38.2% 21.95
Last Price 17.87
52-Week Low 16.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar